#United States #Melville #Cartessa Aesthetics #QUADESSY #Classys Inc

Introducing QUADESSY: The Future of Microneedling

In a significant development for the aesthetic medical field, Cartessa Aesthetics, a leading company from North America, has joined forces with Classys, Inc., a renowned South Korean manufacturer, to launch QUADESSY, an innovative radiofrequency microneedling platform. This groundbreaking technology aims to address the limitations faced by practitioners and patients alike in the current microneedling landscape.

What Makes QUADESSY Different?

QUADESSY is not just another microneedling device; it introduces hybrid technology that seamlessly combines minimally invasive and non-invasive radiofrequency approaches. Its proprietary Hybrid Thermal Coagulation™ technique effectively delivers RF energy across various skin layers, enhancing the remodeling process of both the superficial and deeper dermal structures within a single treatment session. Such a comprehensive method enhances treatment efficiency and patient comfort, making QUADESSY stand out in a crowded market.

One of the most exciting features of QUADESSY is its capacity to significantly reduce treatment time. Procedures that previously took around 45 minutes can now be completed in just 15 minutes without compromising on results. This efficiency is achieved while ensuring that the necessary energy is consistently delivered during the process.

Safety Features to Note

Safety is a primary concern in aesthetic procedures, and QUADESSY addresses this with several advanced technological features. It is equipped with a mechanism that automatically measures skin impedance, adjusting RF output accordingly to ensure precision with each pulse delivered. This commitment to safety ensures reliable outcomes while minimizing potential risks.

Industry Reception and Future Expectations

YS Choi, the Representative Executive Officer of Classys, expressed excitement about bringing QUADESSY to the U.S. market, mentioning the strong uptake of their previous products like EVERESSE and Ultraformer MPT. He emphasized that the U.S. market is at the forefront of aesthetic innovations, and QUADESSY is set to become a benchmark for future developments in the RF microneedling sector.

Gabe Lubin, the Founder and Principal of Cartessa Aesthetics, echoed this commitment to innovation, highlighting QUADESSY’s role in addressing unmet needs in the market. His belief is that as the demand for minimally invasive aesthetic procedures grows, technologies such as QUADESSY will lead the charge in improving treatment safety, efficiency, and predictability.

Customization for Optimal Results

The QUADESSY system comes equipped with three distinct handpieces and various treatment tips, allowing practitioners to customize their approach based on different anatomical areas and treatment indications. This degree of versatility ensures that practitioners can tailor their treatments to meet individual patient needs effectively, enhancing overall satisfaction and results.

Conclusion

As the aesthetic market shifts toward more efficient, safer, and effective treatment options, QUADESSY positions itself as a pivotal player in reshaping the radiofrequency microneedling landscape. Cartessa Aesthetics and Classys strive to meet the evolving expectations of patients and practitioners alike, providing a solution that is not only advanced in technology but also in practical application. For those interested in incorporating QUADESSY into their practices or seeking more information, Cartessa Aesthetics invites you to connect via their website or speak directly with a representative.

For further inquiries, please visit Cartessa Aesthetics.

About the Companies

Cartessa Aesthetics is a pioneer in the North American aesthetic sector, focusing on innovative technologies and providing exceptional support to its clients. Their unique business model, combined with relationships with leading manufacturers, positions them to offer effective solutions that elevate the patient experience.

Classys, Inc., established in 2007, is recognized globally for its contributions to aesthetic technology, with an extensive range of innovative devices deployed in over 80 countries. The company emphasizes continuous R&D to meet the dynamic demands of the medical aesthetics field, ensuring that they remain at the forefront of technology and patient care.